outcomes research

Research in Review

Treatment Advances for Advanced-Stage NSCLC Have Increased Survival

01/05/2017

JCP Editors

Shifts in treatments of advanced-stage non-small cell lung cancer (NSCLC) have resulted in survival and spending gains over time, according to a report published in the Journal of Clinical Oncology. ----- Related...

Shifts...

01/05/2017

Journal of Clinical Pathways

Research in Review

Comparative Effectiveness Report Favors Aromatase Inhibitors Over Tamoxifen for Early-Stage Breast Cancer

01/04/2017

JCP Editors

Treatment with aromatase inhibitors improves outcomes versus treatment with tamoxifen for patients with early-stage breast cancer, according to a report published by the German Institute for Quality and Efficiency in...

...

01/04/2017

Journal of Clinical Pathways

Research in Review

Decreased PSA Screening Leads to Higher Rates of Metastatic Prostate Cancer in Older Men

01/03/2017

JCP Editors

Increase in metastatic prostate cancer in older men has a definitive correlation with changes in prostate cancer screening guidelines recommending against prostate-specific antigen (PSA) testing, according to...

...

01/03/2017

Journal of Clinical Pathways

Research in Review

Ibuprofen May Lower Risk of Lung Cancer Death Among Smokers

12/21/2016

JCP Editors

Regular ibuprofen intake may lower the risk of lung cancer death among individuals with current or past histories of smoking, according to a new study. ----- Related Content New Lung Cancer Biomarker...

...

12/21/2016

Journal of Clinical Pathways

Research in Review

Chemotherapy Regimens Comparable in Efficacy for Treatment of NSCLC

12/20/2016

JCP Editors

Two of the most common chemotherapy regimens may be comparable in terms of efficacy when used in combination with radiotherapy for treatment of non-small cell lung cancer (NSCLC), according to a recent study...

Two of...

12/20/2016

Journal of Clinical Pathways

News

IBM‚Äôs Watson Agrees With Oncologist Treatment Decisions 90% of the Time

12/12/2016

JCP Editors

IBM’s Watson for Oncology, a computer that helps oncologists make treatment decisions for individual patients, made the same recommendations 90% of the time as a team of specialist oncologists, according to a new...

IBM’s...

12/12/2016

Journal of Clinical Pathways

Research in Review

Veliparib Effectiveness for NSCLC Linked to Smoking-Related Genetic Signature

12/06/2016

JCP Editors

Tobacco users with non-small cell lung cancer (NSCLC) have genetic alterations in their tumors that may underlie their increased responsiveness to veliparib, according to new research. ----- Related...

...

12/06/2016

Journal of Clinical Pathways

Few Blood Cancer Patients Receive Recommended CINV Prophylaxis

11/30/2016

JCP Editors

Many patients with hematologic cancers receiving highly emetic chemotherapy regimens do not achieve adequate control of chemotherapy-induced nausea and vomiting (CINV), according to study results presented at the...

Many...

11/30/2016

Journal of Clinical Pathways

Research in Review

Blood Test Helps Predict Treatment Response for Patients With SCLC

11/29/2016

JCP Editors

Patterns of gene copy number aberrations (CNAs) in isolated small-cell lung cancer (SCLC) cells may help determine how patients will respond to chemotherapy, according to a study published...

...

11/29/2016

Journal of Clinical Pathways

Research in Review

Surgery Better Than Neoadjuvant Chemo for Epithelial Ovarian Cancer

11/23/2016

JCP Editors

Primary cytoreductive surgery (PCS) is better than neoadjuvant chemotherapy (NACT) for overall survival in women aged 70 years or younger with advanced-stage epithelial ovarian cancer (EOC), according to a recent...

...

11/23/2016

Journal of Clinical Pathways